Insulin Pump Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2030

Market Overview:

Insulin pumps are very convenient for people who require multiple insulin injections on a daily basis. These devices are less invasive and hence, are largely adopted by the patient pool. The growth of the market is majorly attributed to the increasing geriatric population, growing incidence of diabetes, and the rising prevalence of obesity. Moreover, companies are developing new generation insulin pumps with advanced technology to provide better compliance and integration with IT devices, which is contributing to the growth of the market. Technological developments, including artificial pancreas and home infusion therapy are also anticipated to create significant growth opportunities in the near future.

The global Insulin Pump market was pegged at ~US$ 8.52 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of ~8.7% from 2022 to 2030.

Diabetes is a clinical condition where the inability of the pancreas to produce insulin causes decreased glucose levels in the body. The rapidly changing lifestyle such as the consumption of alcohol and smoking are contributing to the rise in the number of diabetes patients, worldwide. Moreover, the growing prevalence of obesity across the globe is another factor contributing to the high prevalence of diabetes. Type 1 diabetes (T1D) requires continuous monitoring of blood glucose coupled with multiple injections of insulin, thereby increasing the scope for the growth of pumps and other insulin delivery devices and glucose monitors. An insulin pump is a machine that enables insulin to be delivered either manually or automatically. These pumps can be programmed to deliver a specific set of doses and can also deliver a larger set of doses of insulin whenever required, such as before a meal.

The Sample PDF of this research study, please request here:
https://growthplusreports.com/inquiry/request-sample/insulin-pump-market/7798

Key players:

• Valeritas, Inc.
• Ypsomed AG
• Insulet Corporation
• F. Hoffmann-La Roche Ltd.
• Tandem Diabetic Care, Inc.
• Cellenovo
• Sooil Development
• Nipro Diagnostic, Inc.
• Microtech Medical
• Medzer Ltd.

Segmentation By Pump Type:

• Patch Pump
• Tethered Pump

By Disease Indication:

• Type 1 Diabetes
• Type 2 Diabetes

Regional Analysis-

• The Asia-Pacific market is anticipated to grow at a higher CAGR during the forecast period.

• Major factors contributing to the growth of Insulin Pump market in this region include the rising incidence of chronic infectious diseases, rising awareness regarding growing applications of Insulin Pump, and increasing research activities in the field of Insulin Pump.

• The emergence of local players and new product launches has also played a critical role in boosting the Insulin Pump market in this region.

Browse the full report now:
https://growthplusreports.com/report/insulin-pump-market/7798

Key Questions Answered in the Report Include:

(1) This report gives all the information about the industry analysis, revenue, and overview, of this market.

(2) What will be the rate of increase in market size and growth rate by the end of the forecast period?

(3) What are the major global Insulin Pump Market trends influencing the development of the market?

(4) What are the vital results of SWOT analysis of the major players operating in the Insulin Pump Market?

(5) What are the potential growth opportunities and threats faced by Major competitors in the market?

Manan Sethi
Director, Market Insights
Email: enquire@growthplusreports.com
Phone no: +91 96545 76783
Web: https://growthplusreports.com/

Growth+Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association). Growth+ portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis, and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success. We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.

This release was published on openPR.